These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Medication for attention deficit hyperactivity disorder: commentary and response. Faigel HC; Heiligenstein E J Am Coll Health; 1996 Jul; 45(1):40-1; discussion 41-2. PubMed ID: 8708265 [No Abstract] [Full Text] [Related]
5. Treatment of alcohol and cocaine addiction by the combination of pemoline and fenfluramine: a preliminary case series. Rothman RB J Subst Abuse Treat; 1995; 12(6):449-53. PubMed ID: 8749729 [No Abstract] [Full Text] [Related]
6. Efficacy of bupropion in the treatment of pemoline dependence. Martín Morgado B; Vaz Leal FJ; Bolívar Perálvarez M; Guisado Macías JA Actas Esp Psiquiatr; 2007; 35(4):277-8. PubMed ID: 17592792 [TBL] [Abstract][Full Text] [Related]
7. Intensive and sustained air operations: potential use of the stimulant, pemoline. Nicholson AN; Turner C Aviat Space Environ Med; 1998 Jul; 69(7):647-55. PubMed ID: 9681371 [TBL] [Abstract][Full Text] [Related]
8. Medical use of psychostimulants: an overview. Holmes VF Int J Psychiatry Med; 1995; 25(1):1-19. PubMed ID: 7649714 [No Abstract] [Full Text] [Related]
9. [Comparison of the clinical effect of short-term administration of Pondex, methylphenidate, and placebos in neuroses]. Bojanovský J; Hánysová Z; Bouchal M; Náhunek K; Vanýsek J Act Nerv Super (Praha); 1967 Nov; 9(4):373. PubMed ID: 4388629 [No Abstract] [Full Text] [Related]
11. [Methylphenidate augmentation of fluvoxamine for treatment-resistant depression: a case report and review literature]. Buhagiar K; Cassar J Turk Psikiyatri Derg; 2007; 18(2):179-83. PubMed ID: 17566884 [TBL] [Abstract][Full Text] [Related]
12. Photic responses in "minimal brain dysfunction". Milstein V; Small JG Dis Nerv Syst; 1974 Aug; 35(8):355-7. PubMed ID: 17894071 [No Abstract] [Full Text] [Related]
13. Psychostimulants and treatment resistant depression. Ng B Acta Psychiatr Scand; 2009 Dec; 120(6):502-3; author reply 503. PubMed ID: 19824985 [No Abstract] [Full Text] [Related]
14. Coadministration of phenelzine and methylphenidate for treatment-resistant depression. Shelton Clauson A; Elliott ES; Watson BD; Treacy J Ann Pharmacother; 2004 Mar; 38(3):508. PubMed ID: 14970373 [No Abstract] [Full Text] [Related]
15. Pemoline. An alternative psychostimulant for the management of depressive disorders in cancer patients. Breitbart W; Mermelstein H Psychosomatics; 1992; 33(3):352-6. PubMed ID: 1410212 [No Abstract] [Full Text] [Related]
16. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy. Rao JK; Julius JR; Breen TJ; Blethen SL Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452 [TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of pemoline and magnesium hydroxide as a mild stimulant in geriatric patients. Goldstein BJ; Braunstein J Curr Ther Res Clin Exp; 1968 Sep; 10(9):457-60. PubMed ID: 4386689 [No Abstract] [Full Text] [Related]
18. [Comparison of Pondex, methylphenidate and placebo during short term administration and the effect on serum potassium, calcium and sodium levels in neurotic patients]. Bojanovský J; Hánysová Z Act Nerv Super (Praha); 1967 Nov; 9(4):375-6. PubMed ID: 4388631 [No Abstract] [Full Text] [Related]
19. Severe hypotension in a patient receiving pemoline during general anesthesia. Bohringer CH; Jahr JS; Rowell S; Mayer K Anesth Analg; 2000 Nov; 91(5):1131-3. PubMed ID: 11049895 [TBL] [Abstract][Full Text] [Related]
20. Modafinil augmentation in depressed patients with partial response to antidepressants: a pilot study on self-reported symptoms covered by the Major Depression Inventory (MDI) and the Symptom Checklist (SCL-92). Rasmussen NA; Schrøder P; Olsen LR; Brødsgaard M; Undén M; Bech P Nord J Psychiatry; 2005; 59(3):173-8. PubMed ID: 16208839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]